Process View
The directed movement of azoles, heterocyclic compounds found in many biologically important substances, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "azole transport"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| BLNK | B-cell linker | 0.999 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.997 | ||
| CD81 | CD81 molecule | 0.959 | ||
| SYK | spleen tyrosine kinase | 0.759 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.359 | ||
| SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.307 | ||
| TSPAN4 | tetraspanin 4 | 0.267 | Human | |
| CCK | cholecystokinin | 0.223 | ||
| HCK | hemopoietic cell kinase | 0.223 | ||
| GTF2I | general transcription factor IIi | 0.180 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.174 | ||
| SLA | Src-like-adaptor | 0.123 | ||
| MGAT4B | mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B | 0.121 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.104 | ||
| ALOX5AP | arachidonate 5-lipoxygenase-activating protein | 0.096 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.094 | ||
| GAS7 | growth arrest-specific 7 | 0.087 | ||
| CD151 | CD151 molecule (Raph blood group) | 0.086 | Human | |
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.083 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.082 | ||
| PRKCB | protein kinase C, beta | 0.074 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.071 | ||
| CLCN7 | chloride channel 7 | 0.071 | ||
| LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.071 | ||
| CD19 | CD19 molecule | 0.066 | ||
| CTNS | cystinosis, nephropathic | 0.063 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.060 | ||
| LRMP | lymphoid-restricted membrane protein | 0.057 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.054 | ||
| SELL | selectin L | 0.053 | ||
| PLOD1 | procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 | 0.052 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.048 | ||
| NAGPA | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | 0.047 | ||
| PLD3 | phospholipase D family, member 3 | 0.047 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.046 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.045 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.043 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.043 | ||
| IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.039 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.037 | ||
| EDN1 | endothelin 1 | 0.037 | Rat | |
| FXYD3 | FXYD domain containing ion transport regulator 3 | 0.036 | ||
| MCOLN1 | mucolipin 1 | 0.036 | ||
| CD9 | CD9 molecule | 0.035 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.034 | ||
| CST9L | cystatin 9-like | 0.033 | ||
| MFNG | MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 0.033 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.033 | ||
| ARHGAP15 | Rho GTPase activating protein 15 | 0.032 | ||
| SNX33 | sorting nexin 33 | 0.032 | ||
| HRNR | hornerin | 0.031 | ||
| MAN1B1 | mannosidase, alpha, class 1B, member 1 | 0.031 | ||
| PLA2G15 | phospholipase A2, group XV | 0.029 | ||
| IRF8 | interferon regulatory factor 8 | 0.029 | ||
| CD33 | CD33 molecule | 0.029 | ||
| CD93 | CD93 molecule | 0.029 | ||
| CD52 | CD52 molecule | 0.028 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.028 | ||
| HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.027 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.027 | ||
| CD1D | CD1d molecule | 0.027 | ||
| CECR1 | cat eye syndrome chromosome region, candidate 1 | 0.027 | ||
| EDNRA | endothelin receptor type A | 0.025 | Rat | |
| EMP3 | epithelial membrane protein 3 | 0.024 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.024 | ||
| EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 0.024 | ||
| RHOH | ras homolog gene family, member H | 0.024 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.024 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.023 | ||
| HNF1B | HNF1 homeobox B | 0.022 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.022 | ||
| ZNF295 | zinc finger protein 295 | 0.022 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.021 | ||
| PARVB | parvin, beta | 0.021 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.020 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.020 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.020 | ||
| PRKCQ | protein kinase C, theta | 0.020 | ||
| DPEP2 | dipeptidase 2 | 0.019 | ||
| LYL1 | lymphoblastic leukemia derived sequence 1 | 0.019 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.019 | ||
| FKBP10 | FK506 binding protein 10, 65 kDa | 0.019 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.018 | ||
| NCKAP1L | NCK-associated protein 1-like | 0.018 | ||
| PPP1R15B | protein phosphatase 1, regulatory (inhibitor) subunit 15B | 0.018 | ||
| PLXND1 | plexin D1 | 0.018 | ||
| CALCRL | calcitonin receptor-like | 0.017 | ||
| FAIM3 | Fas apoptotic inhibitory molecule 3 | 0.017 | ||
| CORO1A | coronin, actin binding protein, 1A | 0.017 | ||
| STAP1 | signal transducing adaptor family member 1 | 0.017 | ||
| TLR8 | toll-like receptor 8 | 0.016 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.016 | ||
| ANXA11 | annexin A11 | 0.016 | ||
| RNASE6 | ribonuclease, RNase A family, k6 | 0.016 | ||
| GMFG | glia maturation factor, gamma | 0.016 | ||
| ARRB1 | arrestin, beta 1 | 0.016 | ||
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.016 | ||
| MYO1G | myosin IG | 0.015 | ||
| CD180 | CD180 molecule | 0.015 | ||
| ELMO1 | engulfment and cell motility 1 | 0.015 | ||
| SLC6A13 | solute carrier family 6 (neurotransmitter transporter, GABA), member 13 | 0.015 | ||
| WDR81 | WD repeat domain 81 | 0.015 | ||
| MFSD10 | major facilitator superfamily domain containing 10 | 0.015 | ||
| IRF5 | interferon regulatory factor 5 | 0.015 | ||
| CTSD | cathepsin D | 0.015 | ||
| ACTN4 | actinin, alpha 4 | 0.014 | ||
| APBB1IP | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | 0.014 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.014 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.014 | ||
| LAMB2 | laminin, beta 2 (laminin S) | 0.014 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.014 | ||
| PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 0.014 | ||
| RAB17 | RAB17, member RAS oncogene family | 0.014 | ||
| TMEM38B | transmembrane protein 38B | 0.014 | ||
| BANK1 | B-cell scaffold protein with ankyrin repeats 1 | 0.014 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.013 | ||
| CST3 | cystatin C | 0.013 | ||
| GPX1 | glutathione peroxidase 1 | 0.013 | ||
| CCDC3 | coiled-coil domain containing 3 | 0.013 | ||
| IPO13 | importin 13 | 0.013 | ||
| MNDA | myeloid cell nuclear differentiation antigen | 0.013 | ||
| CD72 | CD72 molecule | 0.013 | ||
| HMHA1 | histocompatibility (minor) HA-1 | 0.013 | ||
| HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.013 | ||
| CSRP1 | cysteine and glycine-rich protein 1 | 0.013 | ||
| AGR2 | anterior gradient homolog 2 (Xenopus laevis) | 0.013 | ||
| PLEC | plectin | 0.013 | ||
| FKBP2 | FK506 binding protein 2, 13kDa | 0.013 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.013 | ||
| CD69 | CD69 molecule | 0.013 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.013 | ||
| HSD11B2 | hydroxysteroid (11-beta) dehydrogenase 2 | 0.012 | ||
| PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.012 | ||
| FAM65A | family with sequence similarity 65, member A | 0.012 | ||
| PRKD1 | protein kinase D1 | 0.012 | ||
| HYAL2 | hyaluronoglucosaminidase 2 | 0.012 | ||
| SELPLG | selectin P ligand | 0.012 | ||
| CD48 | CD48 molecule | 0.012 | ||
| ACADVL | acyl-CoA dehydrogenase, very long chain | 0.012 | ||
| TLR6 | toll-like receptor 6 | 0.012 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.012 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.012 | ||
| COL8A1 | collagen, type VIII, alpha 1 | 0.012 | ||
| PNOC | prepronociceptin | 0.012 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.012 | ||
| FLI1 | Friend leukemia virus integration 1 | 0.012 | ||
| HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D | 0.012 | ||
| IGJ | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | 0.012 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.012 | ||
| C19orf21 | chromosome 19 open reading frame 21 | 0.012 | ||
| EDNRB | endothelin receptor type B | 0.012 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.011 | ||
| ERP27 | endoplasmic reticulum protein 27 | 0.011 | ||
| ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | 0.011 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.011 | ||
| TSPAN15 | tetraspanin 15 | 0.011 | ||
| TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 0.011 | ||
| CD38 | CD38 molecule | 0.011 | ||
| PRR15L | proline rich 15-like | 0.011 | ||
| HYAL3 | hyaluronoglucosaminidase 3 | 0.011 | ||
| ABP1 | amiloride binding protein 1 (amine oxidase (copper-containing)) | 0.011 | ||
| TCL1A | T-cell leukemia/lymphoma 1A | 0.011 | ||
| CRY1 | cryptochrome 1 (photolyase-like) | 0.011 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.011 | ||
| SLC12A1 | solute carrier family 12 (sodium/potassium/chloride transporters), member 1 | 0.011 | ||
| ST8SIA3 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | 0.011 | ||
| GPX7 | glutathione peroxidase 7 | 0.011 | ||
| MGLL | monoglyceride lipase | 0.011 | ||
| CD27 | CD27 molecule | 0.011 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.011 | ||
| PTGFRN | prostaglandin F2 receptor negative regulator | 0.011 | ||
| S100A14 | S100 calcium binding protein A14 | 0.011 | ||
| TMBIM1 | transmembrane BAX inhibitor motif containing 1 | 0.011 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.011 | ||
| RHBDF1 | rhomboid 5 homolog 1 (Drosophila) | 0.011 | ||
| TTC38 | tetratricopeptide repeat domain 38 | 0.011 | ||
| KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.011 | ||
| AMOTL2 | angiomotin like 2 | 0.011 | ||
| PEPD | peptidase D | 0.011 | ||
| FUT3 | fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | 0.011 | ||
| FICD | FIC domain containing | 0.011 | ||
| PDLIM1 | PDZ and LIM domain 1 | 0.010 | ||
| EPB49 | erythrocyte membrane protein band 4.9 (dematin) | 0.010 | ||
| PPTC7 | PTC7 protein phosphatase homolog (S. cerevisiae) | 0.010 | ||
| LAT2 | linker for activation of T cells family, member 2 | 0.010 | ||
| CD300A | CD300a molecule | 0.010 | ||
| MFAP2 | microfibrillar-associated protein 2 | 0.010 | ||
| PARVG | parvin, gamma | 0.010 | ||
| CNN2 | calponin 2 | 0.010 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.010 | ||
| KDM5D | lysine (K)-specific demethylase 5D | 0.010 | ||
| IRF6 | interferon regulatory factor 6 | 0.010 | ||
| LRRC33 | leucine rich repeat containing 33 | 0.010 | ||
| NPHP1 | nephronophthisis 1 (juvenile) | 0.010 |